Home › Companies › CEREVEL THERAPEUTICS HOLDINGS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CEREVEL THERAPEUTICS HOLDINGS INC.’s Form 8-K, filed February 16, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of February 16, 2024: 2 items on CEREVEL THERAPEUTICS HOLDINGS INC.’s Form 8-K, filed February 16, 2024: 2 approved.
Notable dissent: 1 say-on-pay vote (76.1% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024
Explore CEREVEL THERAPEUTICS HOLDINGS INC. in the interactive database Compare manager voting policies
These tallies are CEREVEL THERAPEUTICS HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed February 16, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. The Merger Proposal: To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of December 6, 2023, by and among AbbVie Inc., a Delaware corporation ("AbbVie"), Symphony Harlan LLC | 168,829,974 | 2,351 | 69,139 | -- | -- | 99.9% | Approved | — |
| 2. The Merger Compensation Proposal: To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is based on or otherwise relates to the Merger (the " | 128,428,961 | 40,275,201 | 197,302 | -- | -- | 76% | Approved | — |
Source: CEREVEL THERAPEUTICS HOLDINGS INC., Form 8-K, filed with the SEC on February 16, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
206 asset managers disclosed a vote on at least one CEREVEL THERAPEUTICS HOLDINGS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CEREVEL THERAPEUTICS HOLDINGS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the ''Merger Agreement''), dated as of December 6, 2023, by and among AbbVie Inc., a Delaware corporation (''AbbVie''), Symphony Harlan LLC, a Delaware limited liability company and a wholly owned subsidiary of AbbVie (''Intermediate Holdco''), Symphony Harlan Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Intermediate Holdco (''Merger Sub''), and Cerevel Therapeutics Holdings, Inc. (''Cerevel''), pursuant to which Merger Sub will be merged with and into Cerevel, with Cerevel surviving as a wholly owned subsidiary of AbbVie (the ''Merger'');
CEREVEL THERAPEUTICS HOLDINGS INC.’s own tally for this item (“1. Proposal No. 1 - The Merger Proposal: To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of December 6, 2023, by and among AbbVie Inc., a Delaware corp”): 168,829,974 for, 2,351 against — passed, per its Form 8-K filed February 16, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Merger Proposal was approved by the requisite vote of Cerevel's stockholders.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 72 asset managers below reported 24,414,302 for, 62,560 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,167,417 | 0 | 0 | 0 | For |
| Fidelity | 6,735,072 | 0 | 0 | 0 | For |
| BlackRock | 3,207,175 | 0 | 0 | 0 | For |
| State Street | 888,392 | 0 | 0 | 0 | For |
| Charles Schwab | 649,398 | 0 | 0 | 0 | For |
| MERGER FUND | 560,970 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,000 | 0 | 0 | 0 | For |
| AQR | 478,456 | 0 | 0 | 0 | For |
| T. Rowe Price | 439,726 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 426,378 | 0 | 0 | 0 | For |
| Capital Group | 357,691 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 336,770 | 0 | 0 | 0 | For |
| Calamos | 306,460 | 0 | 0 | 0 | For |
| American Century | 296,397 | 0 | 0 | 0 | For |
| Equitable | 185,364 | 0 | 62,560 | 0 | Mixed |
| TIAA | 205,559 | 0 | 0 | 0 | For |
| New York Life | 171,439 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,894 | 0 | 0 | 0 | For |
| Gabelli | 110,000 | 0 | 0 | 0 | For |
| Jackson National | 107,549 | 0 | 0 | 0 | For |
| Brighthouse | 101,351 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 97,489 | 0 | 0 | 0 | For |
| Virtus | 86,313 | 0 | 0 | 0 | For |
| AltShares Trust | 70,409 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 65,023 | 0 | 0 | 0 | For |
Showing the 25 largest of 72 asset managers. All 72 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
87% of fund votes cast · no official result
Description as filed by funds: TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES IF NECESSARY TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES IN PERSON OR BY PROXY TO APPROVE THE PROPOSAL TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.
The 71 asset managers below reported 21,222,994 for, 3,187,409 against, 66,455 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,167,417 | 0 | 0 | 0 | For |
| Fidelity | 5,061,522 | 1,673,550 | 0 | 0 | Mixed |
| BlackRock | 3,207,175 | 0 | 0 | 0 | For |
| State Street | 1,294 | 887,098 | 0 | 0 | Against |
| Charles Schwab | 649,398 | 0 | 0 | 0 | For |
| MERGER FUND | 560,970 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 490,000 | 0 | 0 | 0 | For |
| AQR | 478,456 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 439,726 | 0 | 0 | Against |
| ARBITRAGE FUNDS | 426,378 | 0 | 0 | 0 | For |
| Capital Group | 357,691 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 336,770 | 0 | 0 | 0 | For |
| Calamos | 306,460 | 0 | 0 | 0 | For |
| American Century | 296,397 | 0 | 0 | 0 | For |
| Equitable | 185,364 | 0 | 62,560 | 0 | Mixed |
| TIAA | 205,559 | 0 | 0 | 0 | For |
| New York Life | 171,439 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 124,894 | 0 | 0 | 0 | For |
| Gabelli | 110,000 | 0 | 0 | 0 | For |
| Jackson National | 107,549 | 0 | 0 | 0 | For |
| Brighthouse | 23,397 | 77,954 | 0 | 0 | Mixed |
| ALPS ETF Trust | 97,489 | 0 | 0 | 0 | For |
| Virtus | 86,313 | 0 | 0 | 0 | For |
| AltShares Trust | 70,409 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 65,023 | 0 | 0 | 0 | For |
Showing the 25 largest of 71 asset managers. All 71 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
76% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is based on or otherwise relates to the Merger; and
CEREVEL THERAPEUTICS HOLDINGS INC.’s own tally for this item (“2. Proposal No. 2 - The Merger Compensation Proposal: To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is based on o”): 128,428,961 for, 40,275,201 against — passed, per its Form 8-K filed February 16, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Merger Compensation Proposal was approved by the requisite vote of Cerevel's stockholders.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 7,167,417 | 0 | 0 | Against |
| Fidelity | 0 | 6,735,072 | 0 | 0 | Against |
| BlackRock | 0 | 3,207,175 | 0 | 0 | Against |
| State Street | 887,763 | 629 | 0 | 0 | For |
| Charles Schwab | 0 | 649,398 | 0 | 0 | Against |
| MERGER FUND | 560,970 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 490,000 | 0 | 0 | Against |
| AQR | 0 | 478,456 | 0 | 0 | Against |
| T. Rowe Price | 0 | 439,726 | 0 | 0 | Against |
| ARBITRAGE FUNDS | 426,378 | 0 | 0 | 0 | For |
| Capital Group | 0 | 357,691 | 0 | 0 | Against |
| HARBOR FUNDS | 336,770 | 0 | 0 | 0 | For |
| Calamos | 306,460 | 0 | 0 | 0 | For |
| American Century | 0 | 296,397 | 0 | 0 | Against |
| Equitable | 45,387 | 202,537 | 0 | 0 | Mixed |
| TIAA | 0 | 205,559 | 0 | 0 | Against |
| New York Life | 0 | 171,439 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 124,894 | 0 | 0 | Against |
| Gabelli | 110,000 | 0 | 0 | 0 | For |
| Jackson National | 51,859 | 55,690 | 0 | 0 | Mixed |
| Brighthouse | 0 | 101,351 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 97,489 | 0 | 0 | Against |
| Virtus | 86,313 | 0 | 0 | 0 | For |
| AltShares Trust | 70,409 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 65,023 | 0 | 0 | Against |
Fund voting reports, all 71 managers: 3,100,148 for, 21,345,261 against, 31,449 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Meeder Advisory Services, Inc. | 0 | 158,000,000 | 0 | 0 | Against |
| Fidelity | 0 | 11,470,522 | 0 | 0 | Against |
| PERCEPTIVE ADVISORS LLC | 9,675,292 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 7,555,555 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 2,674,245 | 0 | 0 | 0 | For |
| BlackRock | 17,065 | 2,441,818 | 0 | 0 | Against |
| Paradigm Biocapital Advisors LP | 2,214,019 | 0 | 0 | 0 | For |
| State Street | 2,182,508 | 22,753 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 1,767,186 | 0 | 0 | Against |
| BAKER BROS. ADVISORS LP | 1,600,000 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 1,319,090 | 0 | 0 | Against |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 1,090,317 | 0 | 0 | Against |
| AllianceBernstein | 0 | 901,211 | 0 | 0 | Against |
| Pentwater Capital Management LP | 0 | 900,937 | 0 | 0 | Against |
| Affinity Asset Advisors, LLC | 750,000 | 0 | 0 | 0 | For |
| FARALLON CAPITAL MANAGEMENT LLC | 715,000 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 649,398 | 0 | 0 | Against |
| AQR | 0 | 644,758 | 0 | 0 | Against |
| T. Rowe Price | 0 | 641,235 | 0 | 0 | Against |
| WATER ISLAND CAPITAL LLC | 611,174 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 553,297 | 13,815 | 0 | 0 | For |
| Magnetar Financial LLC | 0 | 488,378 | 0 | 0 | Against |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0 | 458,800 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 393,280 | 0 | 0 | Against |
| Melqart Asset Management (UK) Ltd | 393,066 | 0 | 0 | 0 | For |
No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; every one is in the interactive database (link above).
0% of fund votes cast · no official result
The 3 asset managers below reported 670,665 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 619,108 | 0 | 0 | Against |
| JPMorgan | 0 | 50,892 | 0 | 0 | Against |
| Desjardins Global Asset Management Inc. | 0 | 665 | 0 | 0 | Against |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 7,167,417 |
| 2 | Fidelity | 6,735,072 |
| 3 | BlackRock | 3,207,175 |
| 4 | State Street | 888,392 |
| 5 | Charles Schwab | 649,398 |
| 6 | MERGER FUND | 560,970 |
| 7 | MUTUAL FUND SERIES TRUST | 490,000 |
| 8 | AQR | 478,456 |
| 9 | T. Rowe Price | 439,726 |
| 10 | ARBITRAGE FUNDS | 426,378 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Meeder Advisory Services, Inc. | 158,000,000 |
| 2 | Fidelity | 11,470,522 |
| 3 | PERCEPTIVE ADVISORS LLC | 9,675,292 |
| 4 | Avoro Capital Advisors LLC | 7,555,555 |
| 5 | Rock Springs Capital Management LP | 2,674,245 |
| 6 | BlackRock | 2,458,883 |
| 7 | Paradigm Biocapital Advisors LP | 2,214,019 |
| 8 | State Street | 2,205,261 |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1,767,186 |
| 10 | BAKER BROS. ADVISORS LP | 1,600,000 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to CEREVEL THERAPEUTICS HOLDINGS INC. for the 2023-2024 season, so there is no denominator to divide by.
At CEREVEL THERAPEUTICS HOLDINGS INC.'s shareholder meeting held February 16, 2024, in the 2023-2024 proxy season, 206 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 814 separate fund positions. Their filings are grouped here into 4 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or… — CEREVEL THERAPEUTICS HOLDINGS INC.'s filing reports the proposal as approved, with 76% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CEREVEL THERAPEUTICS HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on February 16, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CEREVEL THERAPEUTICS HOLDINGS INC. proxy season coverage: 2023-2024 (this page).
Proxy Votes Now, “CEREVEL THERAPEUTICS HOLDINGS INC. 2024 Special Meeting: Vote Results”, https://proxyvotesnow.com/company/cerevel-therapeutics-holdings-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.